Literature DB >> 31391224

Patterns of systemic and local inflammation in patients with asthma hospitalised with influenza.

Akhilesh Jha1,2, Jake Dunning1,3, Tanushree Tunstall1, Ryan S Thwaites1, Long T Hoang1, Onn Min Kon1, Maria C Zambon3, Trevor T Hansel1, Peter J Openshaw4.   

Abstract

BACKGROUND: Patients with asthma are at risk of hospitalisation with influenza, but the reasons for this predisposition are unknown. STUDY
SETTING: A prospective observational study of adults with PCR-confirmed influenza in 11 UK hospitals, measuring nasal, nasopharyngeal and systemic immune mediators and whole-blood gene expression.
RESULTS: Of 133 admissions, 40 (30%) had previous asthma; these were more often female (70% versus 38.7%, OR 3.69, 95% CI 1.67-8.18; p=0.0012), required less mechanical ventilation (15% versus 37.6%, Chi-squared 6.78; p=0.0338) and had shorter hospital stays (mean 8.3 versus 15.3 days, p=0.0333) than those without. In patients without asthma, severe outcomes were more frequent in those given corticosteroids (OR 2.63, 95% CI 1.02-6.96; p=0.0466) or presenting >4 days after disease onset (OR 5.49, 95% CI 2.28-14.03; p=0.0002). Influenza vaccination in at-risk groups (including asthma) were lower than intended by national policy and the early use of antiviral medications were less than optimal. Mucosal immune responses were equivalent between groups. Those with asthma had higher serum interferon (IFN)-α, but lower serum tumour necrosis factor, interleukin (IL)-5, IL-6, CXCL8, CXCL9, IL-10, IL-17 and CCL2 levels (all p<0.05); both groups had similar serum IL-13, total IgE, periostin and blood eosinophil gene expression levels. Asthma diagnosis was unrelated to viral load, IFN-α, IFN-γ, IL-5 or IL-13 levels.
CONCLUSIONS: Asthma is common in those hospitalised with influenza, but may not represent classical type 2-driven disease. Those admitted with influenza tend to be female with mild serum inflammatory responses, increased serum IFN-α levels and good clinical outcomes.
Copyright ©ERS 2019.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31391224      PMCID: PMC7612747          DOI: 10.1183/13993003.00949-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   33.795


  40 in total

1.  Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity.

Authors:  Ya-Jen Chang; Hye Young Kim; Lee A Albacker; Nicole Baumgarth; Andrew N J McKenzie; Dirk E Smith; Rosemarie H Dekruyff; Dale T Umetsu
Journal:  Nat Immunol       Date:  2011-05-29       Impact factor: 25.606

2.  Gender differences in prevalence, diagnosis and incidence of allergic and non-allergic asthma: a population-based cohort.

Authors:  Bénédicte Leynaert; Jordi Sunyer; Raquel Garcia-Esteban; Cecilie Svanes; Deborah Jarvis; Isa Cerveri; Julia Dratva; Thorarinn Gislason; Joachim Heinrich; Christer Janson; Nino Kuenzli; Roberto de Marco; Ernst Omenaas; Chantal Raherison; Francisco Gómez Real; Matthias Wjst; Elisabeth Zemp; Mahmoud Zureik; Peter G J Burney; Josep M Anto; Françoise Neukirch
Journal:  Thorax       Date:  2012-02-14       Impact factor: 9.139

Review 3.  Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases.

Authors:  Octavie Rostan; Muhammad Imran Arshad; Claire Piquet-Pellorce; Florence Robert-Gangneux; Jean-Pierre Gangneux; Michel Samson
Journal:  Infect Immun       Date:  2015-02-23       Impact factor: 3.441

4.  Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

Authors:  Elizabeth Miller; Katja Hoschler; Pia Hardelid; Elaine Stanford; Nick Andrews; Maria Zambon
Journal:  Lancet       Date:  2010-01-21       Impact factor: 79.321

Review 5.  Monoclonal antibodies for the treatment of refractory asthma.

Authors:  Nathan Hambly; Parameswaran Nair
Journal:  Curr Opin Pulm Med       Date:  2014-01       Impact factor: 3.155

6.  Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort.

Authors:  Dominick E Shaw; Ana R Sousa; Stephen J Fowler; Louise J Fleming; Graham Roberts; Julie Corfield; Ioannis Pandis; Aruna T Bansal; Elisabeth H Bel; Charles Auffray; Chris H Compton; Hans Bisgaard; Enrica Bucchioni; Massimo Caruso; Pascal Chanez; Barbro Dahlén; Sven-Erik Dahlen; Kerry Dyson; Urs Frey; Thomas Geiser; Maria Gerhardsson de Verdier; David Gibeon; Yi-Ke Guo; Simone Hashimoto; Gunilla Hedlin; Elizabeth Jeyasingham; Pieter-Paul W Hekking; Tim Higenbottam; Ildikó Horváth; Alan J Knox; Norbert Krug; Veit J Erpenbeck; Lars X Larsson; Nikos Lazarinis; John G Matthews; Roelinde Middelveld; Paolo Montuschi; Jacek Musial; David Myles; Laurie Pahus; Thomas Sandström; Wolfgang Seibold; Florian Singer; Karin Strandberg; Jorgen Vestbo; Nadja Vissing; Christophe von Garnier; Ian M Adcock; Scott Wagers; Anthony Rowe; Peter Howarth; Ariane H Wagener; Ratko Djukanovic; Peter J Sterk; Kian Fan Chung
Journal:  Eur Respir J       Date:  2015-09-10       Impact factor: 16.671

Review 7.  Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.

Authors:  Stella G Muthuri; Sudhir Venkatesan; Puja R Myles; Jo Leonardi-Bee; Tarig S A Al Khuwaitir; Adbullah Al Mamun; Ashish P Anovadiya; Eduardo Azziz-Baumgartner; Clarisa Báez; Matteo Bassetti; Bojana Beovic; Barbara Bertisch; Isabelle Bonmarin; Robert Booy; Victor H Borja-Aburto; Heinz Burgmann; Bin Cao; Jordi Carratala; Justin T Denholm; Samuel R Dominguez; Pericles A D Duarte; Gal Dubnov-Raz; Marcela Echavarria; Sergio Fanella; Zhancheng Gao; Patrick Gérardin; Maddalena Giannella; Sophie Gubbels; Jethro Herberg; Anjarath L Higuera Iglesias; Peter H Hoger; Xiaoyun Hu; Quazi T Islam; Mirela F Jiménez; Amr Kandeel; Gerben Keijzers; Hossein Khalili; Marian Knight; Koichiro Kudo; Gabriela Kusznierz; Ilija Kuzman; Arthur M C Kwan; Idriss Lahlou Amine; Eduard Langenegger; Kamran B Lankarani; Yee-Sin Leo; Rita Linko; Pei Liu; Faris Madanat; Elga Mayo-Montero; Allison McGeer; Ziad Memish; Gokhan Metan; Auksė Mickiene; Dragan Mikić; Kristin G I Mohn; Ahmadreza Moradi; Pagbajabyn Nymadawa; Maria E Oliva; Mehpare Ozkan; Dhruv Parekh; Mical Paul; Fernando P Polack; Barbara A Rath; Alejandro H Rodríguez; Elena B Sarrouf; Anna C Seale; Bunyamin Sertogullarindan; Marilda M Siqueira; Joanna Skręt-Magierło; Frank Stephan; Ewa Talarek; Julian W Tang; Kelvin K W To; Antoni Torres; Selda H Törün; Dat Tran; Timothy M Uyeki; Annelies Van Zwol; Wendy Vaudry; Tjasa Vidmar; Renata T C Yokota; Paul Zarogoulidis; Jonathan S Nguyen-Van-Tam
Journal:  Lancet Respir Med       Date:  2014-03-19       Impact factor: 30.700

8.  Impaired innate interferon induction in severe therapy resistant atopic asthmatic children.

Authors:  M R Edwards; N Regamey; M Vareille; E Kieninger; A Gupta; A Shoemark; S Saglani; A Sykes; J Macintyre; J Davies; C Bossley; A Bush; S L Johnston
Journal:  Mucosal Immunol       Date:  2012-12-05       Impact factor: 7.313

9.  Accumulation of human-adapting mutations during circulation of A(H1N1)pdm09 influenza virus in humans in the United Kingdom.

Authors:  Ruth A Elderfield; Simon J Watson; Alexandra Godlee; Walt E Adamson; Catherine I Thompson; Jake Dunning; Mirian Fernandez-Alonso; Deena Blumenkrantz; Tracy Hussell; Maria Zambon; Peter Openshaw; Paul Kellam; Wendy S Barclay
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

10.  Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis.

Authors:  Sudhir Venkatesan; Puja R Myles; Jo Leonardi-Bee; Stella G Muthuri; Malak Al Masri; Nick Andrews; Carlos Bantar; Gal Dubnov-Raz; Patrick Gérardin; Evelyn S C Koay; Tze Ping Loh; Ziad Memish; Elizabeth Miller; Maria E Oliva; Barbara A Rath; Brunhilde Schweiger; Julian W Tang; Dat Tran; Tjasa Vidmar; Pauline A Waight; Jonathan S Nguyen-Van-Tam
Journal:  Clin Infect Dis       Date:  2017-05-15       Impact factor: 9.079

View more
  10 in total

1.  Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection.

Authors:  Maximillian S Habibi; Ryan S Thwaites; Christopher Chiu; Peter J M Openshaw; Meiping Chang; Agnieszka Jozwik; Allan Paras; Freja Kirsebom; Augusto Varese; Amber Owen; Leah Cuthbertson; Phillip James; Tanushree Tunstall; David Nickle; Trevor T Hansel; Miriam F Moffatt; Cecilia Johansson
Journal:  Science       Date:  2020-10-09       Impact factor: 63.714

2.  Asthma and COPD in Hospitalized COVID-19 Patients.

Authors:  Eduardo García-Pachón; Lucía Zamora-Molina; María J Soler-Sempere; Carlos Baeza-Martínez; Justo Grau-Delgado; Isabel Padilla-Navas; Félix Gutiérrez
Journal:  Arch Bronconeumol (Engl Ed)       Date:  2020-05-31       Impact factor: 4.872

Review 3.  Seasonal and pandemic influenza: 100 years of progress, still much to learn.

Authors:  Jake Dunning; Ryan S Thwaites; Peter J M Openshaw
Journal:  Mucosal Immunol       Date:  2020-04-21       Impact factor: 7.313

4.  Circulation of influenza A viruses among patients hospitalized for severe acute respiratory infection in a tertiary care hospital in Romania in the 2018/19 season: Results from an observational descriptive epidemiological study.

Authors:  Anca Cristina Drăgănescu; Victor Daniel Miron; Anca Streinu-Cercel; Dragoş Florea; Ovidiu Vlaicu; Anuţa Bilaşco; Dan Oţelea; Monica Luminiţa Luminos; Daniela Piţigoi; Adrian Streinu-Cercel; Oana Săndulescu
Journal:  Medicine (Baltimore)       Date:  2021-12-30       Impact factor: 1.889

5.  Co-infecting pathogens can contribute to inflammatory responses and severe symptoms in COVID-19.

Authors:  Liping Chen; Lihan Shen; Weichen Wu; Wenda Guan; Jinchao Zhou; Gengyan Luo; Qimin Chen; Hongxia Zhou; Zhenxuan Deng; Yaoqing Chen; Wenjing Zhao; Wenxiang Jin; Minshan Qiu; Qianwei Zheng; Yutao Wang; Chen Liu; Xiangxiang Bai; Deyin Guo; Edward C Holmes; Nanshan Zhong; Mang Shi; Zifeng Yang
Journal:  J Thorac Dis       Date:  2022-02       Impact factor: 2.895

Review 6.  Vulnerability for Respiratory Infections in Asthma Patients: A Systematic Review.

Authors:  Sucheta Sharma; Nishat Tasnim; Kuchalambal Agadi; Ummul Asfeen; Jatin Kanda
Journal:  Cureus       Date:  2022-09-06

7.  Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights.

Authors:  Peter Ab Wark; Prabuddha S Pathinayake; Mathew Suji Eapen; Sukhwinder Singh Sohal
Journal:  Eur Respir J       Date:  2021-07-08       Impact factor: 16.671

8.  Why asthma might surprisingly protect against poor outcomes in COVID-19.

Authors:  Hugo Farne; Aran Singanayagam
Journal:  Eur Respir J       Date:  2020-12-10       Impact factor: 16.671

Review 9.  Insights Into Type I and III Interferons in Asthma and Exacerbations.

Authors:  Helen E Rich; Danielle Antos; Natalie R Melton; John F Alcorn; Michelle L Manni
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

10.  Asthma prevalence in patients with SARS-CoV-2 infection detected by RT-PCR not requiring hospitalization.

Authors:  Eduardo Garcia-Pachon; Lucia Zamora-Molina; Maria J Soler-Sempere; Carlos Baeza-Martinez; Justo Grau-Delgado; Vicente Canto-Reig; Antonio Ramon-Sanchez; Isabel Padilla-Navas; Montserrat Ruiz-Garcia; Nieves Gonzalo-Jimenez
Journal:  Respir Med       Date:  2020-07-04       Impact factor: 4.582

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.